TY - JOUR
T1 - Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks
AU - Galligan, James J.
AU - Wepy, James A.
AU - Streeter, Matthew D.
AU - Kingsley, Philip J.
AU - Mitchener, Michelle M.
AU - Wauchope, Orrette R.
AU - Beavers, William N.
AU - Rose, Kristie L.
AU - Wang, Tina
AU - Spiegel, David A.
AU - Marnett, Lawrence J.
N1 - Funding Information:
and the SENS Foundation (to D.A.S.). The Vanderbilt University Medical Center Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (Grant P30 CA068485) and the Vanderbilt Digestive Disease Research Center (Grant DK058404). Vanderbilt Technologies for Advanced Genomics (VANTAGE) is supported in part by the Clinical and Translational Science Awards Program (Grant 5UL1 RR024975-03), the Vanderbilt Ingram Cancer Center (Grant P30 CA68485), the Vanderbilt Vision Center (Grant P30 EY08126), and National Center for Research Resources (Grant G20 RR030956). Supplemental funding to VANTAGE and Vanderbilt Technologies for Advanced Genomics Analysis and Research Design is provided by National Institutes of Health Grants P50 GM115305 and U19 HL065962.
Funding Information:
ACKNOWLEDGMENTS. We thank William P. Tansey and Carol A. Rouzer for their thoughtful discussions and input. Financial support was provided by National Institutes of Health Grants CA87819 and S10 OD017997 (to L.J.M.)
Funding Information:
We thank William P. Tansey and Carol A. Rouzer for their thoughtful discussions and input. Financial support was provided by National Institutes of Health Grants CA87819 and S10 OD017997 (to L.J.M.) and the SENS Foundation (to D.A.S.). The Vanderbilt University Medical Center Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (Grant P30 CA068485) and the Vanderbilt Digestive Disease Research Center (Grant DK058404). Vanderbilt Technologies for Advanced Genomics (VANTAGE) is supported in part by the Clinical and Translational Science Awards Program (Grant 5UL1 RR024975-03), the Vanderbilt Ingram Cancer Center (Grant P30 CA68485), the Vanderbilt Vision Center (Grant P30 EY08126), and National Center for Research Resources (Grant G20 RR030956). Supplemental funding to VANTAGE and Vanderbilt Technologies for Advanced Genomics Analysis and Research Design is provided by National Institutes of Health Grants P50 GM115305 and U19 HL065962.
Publisher Copyright:
© 2018 National Academy of Sciences. All Rights Reserved.
PY - 2018/9/11
Y1 - 2018/9/11
N2 - Histone posttranslational modifications (PTMs) regulate chromatin dynamics, DNA accessibility, and transcription to expand the genetic code. Many of these PTMs are produced through cellular metabolism to offer both feedback and feedforward regulation. Herein we describe the existence of Lys and Arg modifications on histones by a glycolytic by-product, methylglyoxal (MGO). Our data demonstrate that adduction of histones by MGO is an abundant modification, present at the same order of magnitude as Arg methylation. These modifications were detected on all four core histones at critical residues involved in both nucleosome stability and reader domain binding. In addition, MGO treatment of cells lacking the major detoxifying enzyme, glyoxalase 1, results in marked disruption of H2B acetylation and ubiquitylation without affecting H2A, H3, and H4 modifications. Using RNA sequencing, we show that MGO is capable of altering gene transcription, most notably in cells lacking GLO1. Finally, we show that the deglycase DJ-1 protects histones from adduction by MGO. Collectively, our findings demonstrate the existence of a previously undetected histone modification derived from glycolysis, which may have far-reaching implications for the control of gene expression and protein transcription linked to metabolism.
AB - Histone posttranslational modifications (PTMs) regulate chromatin dynamics, DNA accessibility, and transcription to expand the genetic code. Many of these PTMs are produced through cellular metabolism to offer both feedback and feedforward regulation. Herein we describe the existence of Lys and Arg modifications on histones by a glycolytic by-product, methylglyoxal (MGO). Our data demonstrate that adduction of histones by MGO is an abundant modification, present at the same order of magnitude as Arg methylation. These modifications were detected on all four core histones at critical residues involved in both nucleosome stability and reader domain binding. In addition, MGO treatment of cells lacking the major detoxifying enzyme, glyoxalase 1, results in marked disruption of H2B acetylation and ubiquitylation without affecting H2A, H3, and H4 modifications. Using RNA sequencing, we show that MGO is capable of altering gene transcription, most notably in cells lacking GLO1. Finally, we show that the deglycase DJ-1 protects histones from adduction by MGO. Collectively, our findings demonstrate the existence of a previously undetected histone modification derived from glycolysis, which may have far-reaching implications for the control of gene expression and protein transcription linked to metabolism.
KW - DJ-1
KW - Glyoxalase 1
KW - Histone
KW - Methylglyoxal
KW - QuARKMod
UR - http://www.scopus.com/inward/record.url?scp=85052998012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052998012&partnerID=8YFLogxK
U2 - 10.1073/pnas.1802901115
DO - 10.1073/pnas.1802901115
M3 - Article
C2 - 30150385
AN - SCOPUS:85052998012
VL - 115
SP - 9228
EP - 9233
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
SN - 0027-8424
IS - 37
ER -